Latest Stock Market News

The cash burn is not a question here. The question here is that Blinkit has always focused on assortment, on user experience, and on trying to basically be better ahead of peers. Their focus remains to be on that and not on cash burn.

Tube Investments 0.7% as Sensex

Updated at : 2025-01-21 11:25:01

Rate this item

(1 Vote)

The stock traded at a P/E multiple of 57.44, while the price-to-book value ratio stood at 14.15.

Gold and silver futures saw higher trading on January 20, 2025, with gold at Rs 78,850/10 grams and silver at Rs 92,064/kg. Gold prices surged by Rs 2,400 and silver by Rs 3,700 in the last month. Amid geopolitical tensions and market volatility, analysts expect continued fluctuations in prices, with support and resistance levels identified for both metals.

As India prepares for the Union Budget, ITC investors watch for potential cigarette tax policies. Brokerage Nuvama predicts a modest tax hike, despite urban slowdown. ITC’s cigarette business shows growth potential, but FMCG struggles. Nuvama retains a ‘buy’ rating with a target price of Rs 571, implying a 29% upside from current levels.

ICICI Lombard shares 0.15% as Nifty drops

Updated at : 2025-01-21 11:25:01

Rate this item

(1 Vote)

A total of 3,112 shares changed hands on the counter till 11:03AM (IST).

Leading brokerage firms have given mixed reviews for Tech Mahindra post-Q3 results, with predictions ranging from a 5% to 14% upside. Nomura recommends a Buy with a target of Rs 1,900, Morgan Stanley suggests an Equal Weight rating, while Citi assigns a Sell rating lowering the target to Rs 1,440.

Vedanta shares 1.17% as Sensex falls

Updated at : 2025-01-21 11:25:01

Rate this item

(1 Vote)

On the technical charts, the RSI of the stock stood at 50.64.

Rate this item

(1 Vote)

JM Financial maintains a hold rating on Zydus Lifesciences, setting a target price of Rs 1,090. The quarterly income has dropped by 15.40% from the previous quarter but increased by 19.95% compared to the same quarter last year. Despite facing Asacol HD competition, Zydus Lifesciences’ gradual impact is anticipated, with promoters holding a 74.98% stake.

Waaree Renewable secured a Rs 277.20 crore order to establish a 105 MWp (DC) capacity ground-mounted solar project. The order, awarded by a leading wind energy company, is scheduled for completion in FY 2025-26. The company has delivered strong stock returns, with 86.04% growth over the last year and 1,388.9% over three years.

Warning! Information Posting in this website is only for educational purpose. We are not responsible for losses incurred in Trading based on this information.